Development of the Cold Agglutinin Disease Symptoms and Impact Questionnaire (CAD-SIQ)

Florence Joly1, Pronabesh DasMahapatra2, Dana B DiBenedetti3

  • 1Sanofi, Chilly-Mazarin, France.

Insights

This study identified key symptoms and impacts of cold agglutinin disease (CAD) in patients. A new questionnaire was developed to measure these patient-reported outcomes for better CAD management.

Area of Science:

  • Hematology
  • Autoimmune Diseases
  • Patient-Reported Outcomes

Background:

  • Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia.
  • Understanding patient-centered symptoms and impacts is crucial for managing CAD.
  • Existing measures may not fully capture the lived experience of CAD patients.

Purpose of the Study:

  • To identify disease-related symptoms and impacts significant to patients with CAD.
  • To develop and validate a novel, CAD-specific patient-reported outcome measure.

Main Methods:

  • Concept elicitation (CE) interviews were conducted with adult CAD patients to identify key symptoms and impacts.
  • Cognitive debriefing (CD) interviews were used to refine a draft item set.
  • Standard survey methodological principles guided item development and refinement.

Main Results:

  • 37 adults with CAD participated in interviews.
  • The most frequently reported symptoms were cold sensitivity and fatigue.
  • Negative impacts included limitations on daily and enjoyable activities, mood, and anxiety.

Conclusions:

  • A novel 11-item questionnaire, the CAD-Symptoms and Impact Questionnaire, was developed.
  • This measure captures symptoms and impacts important to patients with CAD.
  • The questionnaire provides a valuable tool for assessing the patient experience in CAD.
Abstract

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.1K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
379
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
16